Clinical Trial Update: Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is underway to test whether quetiapine can reduce post-concussive syndrome symptoms following mild traumatic brain injury, with recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-concussion Syndrome
• Traumatic Brain Injury

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: Foundation for Advancing Veterans' Health Research | Conditions: Mild Traumatic Brain Injury | Phase 3 | Status: RECRUITING